Pregnant women
Conditions
Interventions
None listed
Sponsors
Department of Hospital Pharmacy, Hamamatsu University School of Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Perinatal women 2. Patients from whom written informed consent was obtained
Exclusion criteria
Exclusion criteria: 1.Patients assessed as inappropriate for the study enrollment by the attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The plasma concentrations of OATP1B biomarkers during pregnancy | — |
Countries
Japan
Contacts
Public ContactTakafumi Naito
Hamamatsu University School of Medicine Department of Hospital pharmacy
Outcome results
None listed